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In this study, aloe fermentation products were derived from mycelia from 3 mushrooms: Ganoderma
lucidum (AG), Hericium erinaceum (AH), and Phellinus linteus (AP). Levels of aloin A and B increased
with fermentation time. The highest levels were measured on the fifth day of fermentation. β-Glucan
levels decreased with fermentation time. The safety of aloe fermentation products were examined in male
and female Sprague-Dawley rats. Rats were orally administered the three aloe fermentation products at
dose levels of 1, 2 or 5 g/kg for single-dose toxicity test and 0.5, 1, or 2 g/kg for repeated-dose toxicity
test. There were no significant differences in body weight gain between vehicle control and AG-, AH- or
AP-treated rats. Also, significant changes in daily feed intake and water consumption were not observed.
In hematological analysis, none of the parameters were affected by aloe fermentation products with
mushroom mycelia. This suggests that there are no negative effects on homeostasis and immunity. In
blood biochemistry analysis, none of the markers were affected by feeding rats with AG, AH or AP.
Similarly, there were no significant effects on markers for liver, kidney, skeletal and heart muscle
functions. No remarkable lesions were observed in these organs at histopathology. Since there were no
adverse effects of AG, AH and AP in single- or repeated-dose toxicity tests, even at higher doses than
normal, we conclude that the aloe fermentation products with mushroom mycelia possess long-term
safety and could be candidates as multifunctional nutrients for the improvement of intestinal function and
immunity.
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Aloe is a perennial plant taxonomically grouped under the
phylum Aloe, order Lily and family Liiaceae. It has been
used as an herbal medicine for 3,000 years [1]. Currently,
the leaves of Aloe vera, Aloe arborescence, and Aloe saponaria
are used as health promoting foods. Aloe gel is obtained
from bigger leaves of Aloe vera and prepared as a health
functional food by removing the non-edible parts and peeling
off the epicarp. The main ingredients of Aloe vera gel are
a polysaccharide polymer, alomichin, aloin, aloetic acid and
aloe ulcin, which have antitumor effects, strengthen immunity,
enhance cell reproduction and improve stomach function
[2-6]. Despite these various effects of Aloe vera gel, its use
is limited to its being a notification functional food for
‘improving intestinal function and immunity’ and ‘skin care’
by the Korea Food and Drug Administration (KFDA). Although
several studies on aloe have indicated its usefulness in
improving gastrointestinal function [2-6], those studies are not
recognized by KFDA. Aloe gel as a heath functional food
notification material is consumed directly in its natural state.
The biggest problem is the conventional image of aloe, because
it can be consumed directly from raw material. Stocking is
also a major problem as aloe gel is a jelly. However, there
are many studies that described product differentiation for
aloe usage [3,5].
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Mushrooms contain a greater variety of nutrition (such as
carbohydrates, protein, vitamins and minerals) than vegetables.
They have been used as food and medicine since ancient
times and are regarded by some people as a favorite food
on account of their unique taste and flavor [7]. Recently,
there have been many scientific studies on the ability of
mushrooms to improve immunity, lower cholesterol, normalize
blood-sugar levels, and to have anti-cancer, anti-microbial
and antihypertensive effects [8-13]. In particular, a liquid culture
method using the mushroom mycelium, which enables the
production of large amounts of bioactive compounds in a
short period of time and at lower cost, has been studied
for possible utilization on an industrial scale. Ganoderma
lucidum, which was used in our study, is in the Polyporaceae
of basidiomycetes family and is used a diuretic, a tonic, and
for improving immunity against anti-cancer [11,14-16]. It was
proven safe in an animal experiment of acute and subacute
toxicity using extracts of the whole plant. The second
mushroom used in this study, Hericium erinaceum, has also
been used as food and medicine for a long time. It is effective
in chronic gastritis, cancer (especially gastric cancer), and in
physical weakness. In a recent study, material for a potential
Alzheimer cure was extracted into hot water from Hericium
erinaceum. The hot-water extract also had anti-tumor effects
– it restricted cancer cell proliferation. Hericium erinaceum
contains β-glucan, which enhances immunity and prevents
arteriosclerosis [17-19]. The third mushroom used in this study
is Phellinus linteus. It is effective in improving immunity during
chemotheraphy after cancer surgery, especially for
gastrointestinal malignancies such as stomach, esophagus,
duodenum, colon, rectum and liver cancers. It also has effects
on metrorrhagia, leukorrhea, irregular menstruation,
enterohemorrhage. It improves stomach function and can
be used for detoxification [16].
There have been no reports on the nutritional and toxic
effects of products from the above mushrooms that have
been fermented in aloe. In this study , we examined a new
and improved functional material of aloe fermented using
mushroom strains. For safety evaluation and standardization
of the fermentation products, single-dose and repeated-dose
toxicity tests were performed with the standard being toxicity
tests of KFDA (Regulation 1999-61).
Materials and Methods
Experimental animals
Male and female healthy Sprague-Dawley rats (150-200
g), from Daehan Bio-Link Inc. (Eumsung, Korea), were used
after 1-week acclimation to the laboratory environment. The
experiment was performed in the animal laboratory under
conditions of 23±3
oC, a relative humidity of 55±15%, 12
h of lighting (08:00-20:00) at 150-300 Lux of brightness.
During the experimental period, the rats were kept in stainless
mesh cages (220W×410L×200H mm). Two to three rats in
each cage were kept for the adjustment, during the test product
administration and observation periods. The animal
experiments were performed with permission from The Ethics
Committee of Animal Experiments at Chungbuk National
University, Korea.
Materials
Ganoderma lucidum (KCTC 6729) and Phellinus linteus
(KCTC 6719) were used as standard strains. They were acquired
from the Gene Bank of The Korea Biological Resource Center.
Hericium erinaceum was obtained from the Food-Engineering
Department of Chungju National University (Jeungpyeong,
Korea). Each strain was cultivated in potato dextrose agar
(PDA, Difco, Detroit, USA) by 15 days of subculturing [18,20].
Aloe (Aloe vera) was purchased from JejuSamda Aloe (Jeju,
Korea) in 2009 and 2010. Aloin A and aloin B were from
ChromaDex (Irvine, USA) and were used as standards for
aloe products. Mushroom and yeast β-glucan kits were from
Megazyme (Wicklow, Ireland) and were used for β-glucan
analysis. Levels of aloin A, aloin B and β-glucan were
standardized by analyzing the aloe fermentation products for
a general toxicity evaluation.
Cultivation conditions for strains and manufacturing
of liquid spawn
Manufactured strains of Ganoderma lucidum and Phellinus
linteus (in all liquid cultures) were incubated in PDA medium
for 7 days at 28
oC. Strain discs were created by cutting with
a cork borer (8 mm in diameter). Five to six discs were placed
in an Erlenmeyer flask which contained 100 mL of potato
dextrose broth (PDB, Difco) medium, and then were shaken
and cultured (SI-400R; Jeiotech, Daejeon, Korea) for 6 days.
The culture was then homogenized using a grinder. Nine
milliliters of this was subsequently placed in an Erlenmeyer
flask in which 100 mL of PDB was left for 5 days. These
were used as the main spawn. Hericium erinaceum was
processed by the same method as above but the temperature
was kept at 24
oC [18,20].
Cultivation  of  mushroom  mycelium  in  aloe  as  a
natural medium
To obtain the viscosity of aloe gel, fresh leaves were washed,
peeled and ground. The gel was placed in a fermenter and
sterilized for 20 min at 120
oC. The temperature of theGeneral toxicities of aloe fermentation products 237
Lab Anim Res | September, 2011 | Vol. 27, No. 3
fermenter was rapidly cooled to 25
oC and the resulting aloe
gel was used as a natural medium. Aloe fermentation products
were obtained by cultivating 9% of the liquid spawn in the
gel at an optimum temperature. These aloe fermentation
products were extracted at 85
oC for 6 h, filtered using filter
paper (Advantec 5A; Advantec, Tokyo, Japan), and then
evaporated and freeze-dried (Ilshinbiobase, Dongducheon,
Korea). The freeze dried aloe fermentation products were
used as the experimental samples.
Aloin A and aloin B levels
The concentrations of aloin A and aloin B were determined
using a high performance liquid chromatography system
(Waters 2695; Waters, Milford, USA)-photodiode array
detector (PDA, Waters 996; Waters) with a fixed YMC-PACK
PRO C18 (5 µm 4.6×150 mm AS12S05-1546WT) [21,22].
β-Glucan analysis
One hundred mg of aloe fermentation product was placed
in a 50 mL glass test tube, and 1.5 mL of 37 % hydrochloride
was added. A reaction was made to occur every 15 min
for 45 min in a 30
oC water bath. Ten mL of distilled water
was added and then reacted in boiling water for 5 min and
the contents of the tube were stirred in a 100
oC water bath
for 2 h. They were allowed to cool and then 2 N KOH
(10 mL) was added. The contents were centrifuged at 3,000xg
for 10 min and the supernatant was collected. Exo-1,3-β-
glucosidase (0.1 mL) was added to an equal volume of
supernatant. A reaction was made to occur at 40
oC for 60
min and total glucan was determined. Aloe fermentation
product (100 mg) was placed in a 50 mL glass test tube and
2 M KOH (2 mL) was added and placed in an ice water
bath for 20 min. Next, 1.2 M sodium acetate buffer (pH 3.8,
8 mL) and amyloglucosidase plus invertase (0.2 mL) were
mixed and placed in a 40
oC water bath for 30 min. This
was centrifuged at 3,000×g for 10 min. Then 200 mM sodium
acetate buffer (pH 5.0) was added to the supernatant and
α-glucan levels were determined. Glucose oxidase/peroxidase/
4-amino-anipyrine (GOPOD) reagents (3 mL) were placed
in each of the total glucan and the α-glucan analyzing flasks,
and the flasks were placed in a 40
oC water bath for 20
min. Absorbance was observed at 510 nm and the β-glucan
content (%) in the sample was calculated [14,23].
Manufacturing  and  applying  aloe  fermentation
products
Three aloe fermentation products (Ganoderma lucidum-
aloe fermentation product (AG), Hericium erinaceum-aloe
fermentation product (AH) and Phellinus linteus-aloe
fermentation product (AP) were used for both single-dose
toxicity and repeated-dose toxicity tests. The toxicity tests
were performed for the validity of food safety. Three different
dosages (1, 2 and 5 g/kg) and (0.5, 1 and 2 g/kg) of each
experimental material (AG, AH and AP) were, respectively,
used for single-dose and repeated-dose toxicity tests. They
were orally administered.
Toxicity tests
For single-dose toxicity test, a total of 80 rats were assigned
to vehicle, AG, AH and AP groups, with each group accounting
for 3 dose levels of 4 mice each with a total of 10 groups.
After 24-h fasting, the test materials, dissolved in purified
water, were administered orally using a syringe with a Sonde
needle. According to the guidelines of KFDA and Health
and Welfare Department of Japan, the upper-limit dosage
was set at 5 g/kg (3-dose levels of 1, 2 and 5 g/kg). Feed
were provided after 4 h of test material administration, and
toxicity was evaluated for a 2-week observation period [24-26].
For repeated-dose toxicity tests, the general procedure
followed was the same as the above indicated single-dose
toxicity test except that the 3-dose levels used in repeated-
dose toxicity tests were 0.5, 1 or 2 g/kg without fasting. The
animals were administered for 28 days, and 10 rats were
in each group (a total of 100 rats).
Observation of clinical signs
Based on the Functional Observational Battery (FOB) tests,
such as function of the automatic nervous system, home cage,
open field behaviors, reaction to stimulation, alertness,
vigilance, posture, walking and mortality examinations were
done every day during the experimental period. In addition
to general symptoms, body weight as well as feed and water
intakes were observed and recorded every week. At the end
of the trial, rats were anesthetized with ether, the abdomen
was opened, and the animals were killed by bleeding. Organs
were examined with the naked eyes.
Hematological analysis
Blood was collected from the abdominal artery into an
EDTA tube (BD vacutainer, BD, Franklin Lakes, USA).
Hematocrit, red blood cells (RBC) and RBC indices, platelets,
white blood cells (WBC) and differential counts were analyzed
using a hematology analyzer (Siemens Medical ADVIA 2120,
Bayer, Leverkusen, Germany).
Blood biochemical analysis
Blood was collected from the abdominal artery into a test
tube. After standing for 30 min, the blood was centrifuged238 Ju-Hyun Cho et al.
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for 10 min at 12,000 rpm and the serum was collected.
Hepatic toxicity indices (alanine transaminase, ALT; aspartate
transaminase, AST; alkaline phosphatase, ALP; total proteins,
TP; albumin; total bilirubin, TB; glucose), lipid metabolism
indices (total cholesterol, TC; triglycerides, TG), and renal
toxicity indices (blood urea nitrogen, BUN; creatinine) were
measured using a Clinical Analyzer (Hitachi 7080 Clinical
Analyzer, Hitachi, Tokyo, Japan).
Histopathological findings
For histopathological findings, liver, lung, spleen, kidney,
heart, testis, ovary, adrenal gland, thymus and brain were
collected and fixed in 10% formalin for 3 days. Paraffin-
embedded tissue sections (4 µm in thickness) were stained
with hematoxylin-eosin, and examined with a light
microscope.
Statistics
The data were analyzed by Kruskal-Wallis ANOVA and
are presented as the mean±SD.
Results and Discussion
The contents of aloin and β-D-glucan in the aloe
fermentation products
Since aloin A and B are well known as major active
ingredients in aloe species, we determined the concentration
of aloin A and aloin B in aloe fermentation products AG,
AH and AP . The contents of aloin A in control samples (aloe
alone) or in fermented samples with AG, AH and AP , are
indicated in Table 1. Aloe fermentation with mushroom
mycelia increased the aloin A content in the fermentation
products with the highest level observed in AP followed by
AH; AG had no effect. Similarly, aloin B proportions in all
3 mushroom mycelia-fermented products were significantly
increased: AP>AH>AG.
Since  β-D-glucan is a multi-functional polysaccharide
isolated from aloe species, we examined whether fermentation
treatment affected polysaccharide composition. While the
difference in proportion of β-D-glucan between un-treated
control and Ganoderma lucidum-fermented aloe (AG) were
not significant, AH and AP caused a significantly lowered
β-D-glucan content than control (Table 1).
Toxic symptoms, clinical signs and mortality rates
In the present study, general symptoms, clinical signs and
mortality rates were examined at the given doses of the aloe
fermentation products as indicated in the Materials and
Methods section at 0, 1, 3, and 7 h and then daily for 14
days after treatment. All the aloe fermentation products (AG,
AH and AP) did not cause any symptoms or abnormal clinical
signs, and no deaths were observed during the study period
(data not shown). According to the results from the single-
dose toxicity study, we set the dosage levels at 0.5, 1 and
2 g/kg for repeated-dose toxicity test. In repeated-dose toxicity
test, the results were similar: neither abnormal symptoms,
nor deaths were observed (data not shown). The results indicate
that AG, AH and AP even at upper-limit doses do not induce
any apparent clinical signs.
Feed and water intakes and body weight gains
In single-dose toxicity test, there were no significant
differences in the body weight gain of male and female rats
treated with aloe fermentation products (data not shown).
In repeated-dose toxicity study, daily feed intakes were within
20-30 g and 10-15 g in all groups of male and female animals,
respectively. Also, daily water intakes changed within 25-45
mL and 18-30 mL in male and female rats, respectively. There
were no differences in the feed and water consumptions
between control and aloe fermentation products (AG, AH
and AP)-treated groups.
In addition, there were no differences in body weight gains
between control and treatment groups, ranging from 96.4
to 123.3 mg/day/rat regardless of the doses used (Figure 1),
which may be in correlation with the feed and water intakes.
The above results for single-dose and repeated-dose toxicity
tests suggest that the aloe fermentation products were not
toxic to rats even at the highest (upper-limit) dose of 2 g/kg.
Organ weights
After 4 weeks of treatment, the weight of internal organs
of rats was measured. Liver, kidneys, lung, heart, thymus,
spleen, adrenal glands, and reproductive organs (testes and
epididymides) of aloe fermentation products-treated male rats
were not different from vehicle controls in all groups tested
(Table 2). Similarly, liver, kidneys, lung, heart, thymus, spleen,
adrenal glands, and reproductive organs (uterus and overies)
Table 1. Content of aloin A, aloin B and β-glucan in aloe
fermentation products
Material Aloin A (mg/kg) Aloin B (mg/kg) β-glucan (%)
AN 32.3±1.64 17.1±3.52 11.1±0.65
AG 32.1±1.61 25.9±1.61 11.2±0.92
AH 39.7±3.21 29.9±2.82 2.5±0.11
AP 44.0±1.89 38.8±2.00 4.9±0.35
AN: natural aloe, AG: aloe fermentation product fermented by
Ganoderma lucidum, AH: aloe fermentation product fermented by
Hericium erinaceum, AP: aloe fermentation product fermented by
Phellinus linteus.General toxicities of aloe fermentation products 239
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of female rats were not different between control and treatment
groups (Table 3).
Hematology
The effects of aloe fermentation products on hematological
parameters were determined in order to evaluate whether
the tested products influence the normal values of the blood
composition and their contents. In comparison with the vehicle
control, hematocrit, RBC counts and RBC indices (hemoglobin,
MCV, MCH and MCHC), platelets, WBC counts and their
proportions (%) were not changed by treatment with 3 aloe
fermentation products in female rats (Table 4) as well as in
male animals (data not shown).
Blood biochemistry
Sera were analyzed for the adverse effects (tissue injury
and dysfunction) of aloe fermentation products on tissues
and organs. Table 5 and 6 depicts blood biochemical
Figure 1. Changes in body weights of male and female rats fed aloe fermentation products during oral administration for 28 days.
AG: aloe fermentation product from Ganoderma lucidum, AH: aloe fermentation product from Hericium erinaceum, AP: aloe
fermentation product from Phellinus linteus.2
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Table 2. Organ weights of male rats treated with aloe fermentation products for 4 weeks
Organ Vehicle
AG AH AP
(0.5 g/kg) (1 g/kg) (2 g/kg) (0.5 g/kg) (1 g/kg) (2 g/kg) (0.5 g/kg) (1 g/kg) (2 g/kg)
Liver 10.83±0.490 11.21±0.920 11.31±1.360 11.06±1.200 11.64±1.760 10.90±0.760 11.27±1.950 11.24±0.570 11.30±1.540 11.83±1.570
Kidney (left) 1.27±0.09 1.32±0.06 1.26±0.09 1.34±0.09 1.21±0.13 1.33±0.11 1.25±0.12 1.27±0.05 1.35±0.16 1.35±0.18
Kidney (right) 1.28±0.08 1.32±0.09 1.27±0.05 1.34±0.13 1.26±0.15 1.28±0.11 1.25±0.14 1.29±0.06 1.37±0.14 1.33±0.10
Lung 1.34±0.08 1.46±0.02 1.45±0.13 1.39±0.18 1.45±0.10 1.49±0.13 1.35±0.14 1.44±0.14 1.48±0.07 1.41±0.18
Heart 1.21±0.12 1.17±0.13 1.17±0.15 1.19±0.03 1.17±0.13 1.20±0.07 1.17±0.12 1.15±0.10 1.25±0.13 1.15±0.05
Thymus 0.62±0.10 0.69±0.23 0.56±0.10 0.60±0.09 0.69±0.15 0.65±0.11 0.66±0.14 0.68±0.13 0.64±0.09 0.65±0.14
Spleen 0.79±0.07 0.90±0.11 0.84±0.10 0.80±0.10 0.69±0.37 0.87±0.11 0.82±0.10 0.98±0.44 0.83±0.13 0.79±0.06
Adrenal (left) 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.01 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.00
Adrenal (right)  0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.00 0.02±0.01 0.02±0.01 0.02±0.00
Testis (left) 1.61±0.17 1.64±0.17 1.63±0.07 1.67±0.10 1.55±0.15 1.73±0.09 1.64±0.15 1.69±0.14 1.84±0.04 1.68±0.16
Testis (right) 1.63±0.13 1.61±0.17 1.67±0.07 1.65±0.11 1.58±0.15 1.72±0.06 1.61±0.13 1.64±0.15 1.81±0.06 1.69±0.16
Epididymis (left) 0.42±0.05 0.40±0.03 0.40±0.04 0.40±0.02 0.38±0.02 0.42±0.02 0.41±0.03 0.41±0.05 0.46±0.05 0.40±0.04
Epididymis (right) 0.39±0.02 0.40±0.04 0.38±0.03 0.38±0.02 0.37±0.02 0.41±0.04 0.38±0.03 0.40±0.06 0.44±0.05 0.41±0.04
AG: aloe fermentation product fermented by Ganoderma lucidum, AH: aloe fermentation product fermented by Hericium erinaceum, AP: aloe fermentation product fermented by Phellinus
linteus.
Table 3. Organ weights of female rats treated with aloe fermentation products for 4 weeks
Organ Vehicle
AG AH AP
(0.5 g/kg) (1 g/kg) (2 g/kg) (0.5 g/kg) (1 g/kg) (2 g/kg) (0.5 g/kg) (1 g/kg) (2 g/kg)
Liver 6.60±0.76 6.66±0.83 7.09±0.87 6.88±1.28 6.39±0.82 6.72±1.10 6.37±0.44 6.46±0.76 6.81±0.71 6.97±1.07
Kidney (left) 0.76±0.04 0.80±0.03 0.78±0.07 0.84±0.07 0.77±0.11 0.76±0.05 0.75±0.05 0.76±0.05 0.80±0.09 0.81±0.08
Kidney (right) 0.80±0.09 0.79±0.06 0.76±0.06 0.82±0.08 0.78±0.10 0.73±0.06 0.75±0.02 0.75±0.05 0.78±0.06 0.80±0.09
Lung 1.08±0.11 1.03±0.10 1.09±0.05 1.15±0.12 1.05±0.05 1.13±0.07 1.08±0.07 1.09±0.13 1.12±0.10 1.17±0.07
Heart 0.83±0.12 0.79±0.03 0.80±0.06 0.77±0.20 0.78±0.09 0.79±0.05 0.80±0.07 0.81±0.05 0.77±0.08 0.83±0.07
Thymus 0.50±0.08 0.42±0.07 0.37±0.06 0.54±0.19 0.40±0.09 0.35±0.04 0.46±0.08 0.40±0.09 0.45±0.08 0.45±0.07
Spleen 0.55±0.10 0.52±0.07 0.54±0.08 0.58±0.10 0.53±0.01 0.59±0.06 0.57±0.03 0.54±0.05 0.51±0.05 0.60±0.06
Adrenal (left) 0.03±0.00 0.03±0.00 0.03±0.01 0.04±0.01 0.02±0.01 0.03±0.01 0.03±0.00 0.03±0.00 0.03±0.01 0.03±0.00
Adrenal (right) 0.03±0.01 0.03±0.01 0.03±0.00 0.03±0.01 0.03±0.00 0.03±0.01 0.03±0.00 0.03±0.00 0.03±0.01 0.03±0.01
Uterus 0.52±0.16 0.64±0.30 0.46±0.10 0.42±0.03 0.42±0.07 0.39±0.10 0.47±0.20 0.49±0.09 0.37±0.04 0.43±0.04
Ovary (left) 0.06±0.01 0.05±0.02 0.05±0.01 0.06±0.01 0.04±0.02 0.05±0.02 0.05±0.02 0.05±0.02 0.05±0.02 0.06±0.01
Ovary (right) 0.05±0.01 0.04±0.00 0.05±0.01 0.05±0.02 0.04±0.01 0.05±0.02 0.04±0.01 0.05±0.01 0.04±0.02 0.05±0.00
AG: aloe fermentation product fermented by Ganoderma lucidum, AH: aloe fermentation product fermented by Hericium erinaceum, AP: aloe fermentation product fermented by Phellinus
linteus.G
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Table 4. Hematological analysis of female rats treated with aloe fermentation products for 4 weeks
Parameters Vehicle
AG AH AP
0.5 g/kg 1 g/kg 2 g/kg 0.5 g/kg 1 g/kg 2 g/kg 0.5 g/kg 1 g/kg 2 g /kg
Hematocrit (%) 47.54±2.47 45.93±2.23 46.48±2.15 47.47±0.74 51.14±3.75 49.48±3.32 48.42±3.20 50.58±2.45 48.36±2.00 50.28±3.78
RBC (1×10
6 cells/µL) 7.59±0.30 7.40±0.19 7.46±0.38 7.68±0.25 8.26±0.75 7.93±0.39 7.88±0.44 8.28±0.46 7.93±0.32 8.02±0.49
Hemoglobin (g/dL) 17.52±0.81 16.80±0.72 17.08±0.97 17.23±0.21 19.30±1.87 18.34±0.80 17.92±1.28 18.62±1.08 18.24±0.32 18.60±1.30
MCV (fL) 62.58±1.02 62.10±1.65 62.28±1.21 61.90±2.51 62.06±2.00 62.30±1.82 61.92±1.65 61.10±1.49 61.02±0.63 62.60±1.14
MCH (g/dL) 23.06±0.28 22.73±0.39 22.88±0.62 22.47±0.93 23.36±0.52 23.14±0.51 22.74±0.68 22.48±0.99 23.00±0.91 23.18±0.25
MCHC (g/dL) 36.84±0.80 36.60±0.83 36.75±0.49 36.27±0.25 37.66±1.29 37.12±0.94 36.96±0.36 36.78±0.71 37.68±1.40 37.03±0.35
PLT (1×10
3 cells/µL) 1,127.0±210.8 1,402.3±160.7 1,081.3±129.3 1,100.7±242.7 1,326.5±50.51,380.00±100.61,360.40±155.6 1,260.8±126.51,307.40±168.5 1,330.5±181.3
WBC (1×10
3 cells/µL) 4.06±1.04 4.16±0.69 4.02±0.19 3.99±0.63 3.98±1.20 4.11±0.90 3.91±1.06 3.69±1.66 3.16±0.68 3.28±1.12
Neutrophils (%) 6.25±1.91 6.30±0.85 4.70±1.13 5.85±0.49 6.50±1.51 5.22±1.56 5.92±1.82 5.63±1.20 5.93±1.31 4.53±1.43
Eosinophils (%) 0.78±0.45 1.00±0.36 1.33±0.49 1.05±0.21 1.10±0.36 1.02±0.26 0.76±0.31 0.78±0.19 0.87±0.15 0.85±0.64
Basophils (%) 0.18±0.05 0.13±0.06 0.23±0.06 0.23±0.06 0.13±0.05 0.13±0.06 0.14±0.09 0.18±0.10 0.18±0.08 0.20±0.08
Lymphocytes (%) 89.20±5.03 88.05±3.34 87.75±5.98 87.60±4.97 88.26±4.11 91.46±4.44 91.26±1.62 90.76±2.61 90.18±2.11 89.53±2.99
Monocytes (%) 1.12±0.31 1.58±0.55 1.48±0.21 1.27±0.21 1.08±0.19 1.23±0.47 1.55±0.41 1.53±0.46 1.56±0.27 1.15±0.30
AG: aloe fermentation product fermented by Ganoderma lucidum, AH: aloe fermentation product fermented by Hericium erinaceum, AP: aloe fermentation product fermented by Phellinus
linteus. RBC: red blood cells, MCV: mean corpuscular volume, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, PLT: platelets, WBC: while blood
cells.
Table 5. Blood biochemistry of male rats treated with aloe fermentation products for 4 weeks
Parameters Vehicle
AG AH AP
0.5 g/kg 1 g/kg 2 g/kg 0.5 g/kg 1 g/kg 2 g/kg 0.5 g/kg 1 g/kg 2 g/kg
ALT (U/L) 46.25±8.190 50.32±1.370 41.34±7.080 42.03±6.840 40.20±2.700 41.18±5.830 44.45±6.520 42.98±9.600 40.13±3.810 40.90±1.890
AST (U/L) 196.72±14.81 167.50±17.32 168.00±22.81 164.80±10.73 162.90±11.33 197.87±8.400 177.92±5.360 217.80±11.90 196.40±19.16 203.60±30.87
ALP (U/L) 380.68±50.84 405.38±58.07 362.58±27.06 374.94±15.45 353.55±38.00 366.84±85.70 403.34±53.09 370.72±25.75 378.13±73.19 372.83±58.17
TB (mg/dL) 0.05±0.010 0.03±0.020 0.03±0.010 0.02±0.010 0.02±0.020 0.03±0.010 0.03±0.010 0.03±0.010 0.03±0.010 0.03±0.010
TP (g/dL) 5.06±0.530 5.38±0.170 5.00±0.250 5.62±0.420 5.26±0.230 5.48±0.130 5.78±0.160 5.76±0.130 5.62±0.390 5.60±0.240
Albumin (g/dL) 3.04±0.250 3.16±0.230 3.22±0.210 3.06±0.150 2.70±0.330 2.74±0.370 3.08±0.200 3.14±0.110 2.92±0.100 3.34±0.160
TC (mg/dL) 74.16±7.430 73.70±9.390 77.10±10.03 83.28±5.290 77.96±18.92 82.54±10.55 85.64±15.53 83.16±9.700 83.12±11.28 85.50±10.48
TG (mg/dL) 74.48±11.69 82.20±10.31 82.44±12.86 82.42±16.50 67.45±19.63 73.78±8.500 63.23±8.400 63.08±17.53 64.72±18.19 64.95±8.230
Glucose (mg/dL) 96.76±14.76 113.32±12.51 113.06±8.620 103.25±22.23 112.05±6.810 122.18±18.16 104.72±18.59 87.20±14.39 108.26±19.16 122.22±6.710
BUN (mg/dL) 16.36±2.850 17.23±1.920 15.18±2.570 15.42±2.200 15.37±0.750 17.24±1.090 16.54±0.480 16.92±2.090 15.47±2.040 15.90±1.280
Creatinine (mg/dL) 0.38±0.080 0.42±0.040 0.38±0.040 0.46±0.050 0.38±0.040 0.46±0.050 0.46±0.050 0.46±0.080 0.44±0.050 0.48±0.040
AG: aloe fermentation product fermented by Ganoderma lucidum, AH: aloe fermentation product fermented by Hericium erinaceum, AP: aloe fermentation product fermented by Phellinus
linteus. ALT: alanine transaminase, AST: aspartate transaminase, ALP: alkaline phosphatase, TB: total bilirubin, TP: total proteins, TC: total cholesterol, TG: triglycerides, BUN: blood urea
nitrogen.2
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Table 6. Blood biochemistry of female rats treated with aloe fermentation products for 4 weeks
Parameters Control
AG AH AP
0.5 g/kg 1 g/kg 2 g/kg 0.5 g/kg 1 g/kg 2 g/kg 0.5 g/kg 1 g/kg 2 g/kg
ALT (U/L) 34.66±3.420 36.82±6.280 37.84±4.850 38.74±5.850 36.86±7.820 34.38±5.760 32.74±5.960 34.88±8.470 38.46±3.350 37.06±3.610
AST (U/L) 147.40±23.95 161.75±44.64 175.13±11.78 166.27±15.39 185.63±19.88 167.00±19.85 141.15±21.84 152.60±7.370 152.25±15.61 161.37±46.10
ALP (U/L) 220.33±39.77 231.43±26.61 241.80±27.43 246.80±15.80 202.40±29.29 203.20±23.74 189.35±12.58 230.88±19.23 196.90±16.37 193.80±21.91
TB (mg/dL) 0.17±0.020 0.14±0.040 0.16±0.020 0.14±0.040 0.13±0.030 0.13±0.020 0.13±0.010 0.15±0.010 0.15±0.010 0.13±0.020
TP (g/dL) 5.42±0.490 5.24±0.400 5.76±0.180 5.60±0.140 5.72±0.480 5.64±0.300 5.64±0.350 5.82±0.170 5.48±0.130 5.74±0.550
Albumin (g/dL) 3.92±0.310 3.88±0.350 4.14±0.150 4.14±0.200 4.22±0.360 4.12±0.130 4.12±0.250 4.28±0.130 3.98±0.220 4.22±0.480
TC (mg/dL) 92.12±13.40 82.46±20.15 99.34±17.85 88.22±10.79 96.78±24.37 99.34±17.85 99.34±17.82 94.86±16.56 103.46±11.83 93.02±15.76
TG (mg/dL) 76.28±18.02 71.00±16.44 75.64±17.34 66.83±11.68 66.45±28.86 52.30±6.810 53.75±4.840 51.34±12.31 57.35±16.22 55.83±6.860
Glucose (mg/dL) 107.72±7.750 114.58±18.62 111.43±10.36 116.87±7.290 102.12±14.14 100.48±17.64 104.28±11.68 103.56±17.06 102.12±9.390 111.55±7.250
BUN (mg/dL) 14.12±0.750 13.78±2.350 17.54±0.790 14.60±1.200 16.96±1.240 16.60±2.200 15.72±0.660 15.94±1.350 15.88±2.130 16.98±1.900
Creatinine (mg/dL) 0.42±0.040 0.46±0.050 0.44±0.050 0.54±0.050 0.48±0.040 0.05±0.070 0.46±0.050 0.46±0.050 0.46±0.050 0.50±0.070
AG: aloe fermentation product fermented by Ganoderma lucidum, AH: aloe fermentation product fermented by Hericium erinaceum, AP: aloe fermentation product fermented by Phellinus
linteus. ALT: alanine transaminase, AST: aspartate transaminase, ALP: alkaline phosphatase, TB: total bilirubin, TP: total proteins, TC: total cholesterol, TG: triglycerides, BUN: blood urea
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parameters of rats fed the aloe fermentation products. The
test materials at 3 different doses did not affect the normal
values of all 11 biochemical parameters in both males (Table
5) and females (Table 6). The parameters cover hepatocytic
injury (ALT and AST), cholestasis (ALP and TB), hepatocytic
protein synthesis (TP and albumin), lipid metabolism (TC and
TG), energy synthesis and storage (glucose), and renal
dysfunction (BUN and creatinine).
Histopathological findings
Histopathological examination of the vital organs of the
rats fed aloe fermention products for 4 weeks were determined
using hematoxylin-eosin staining techniques. All 3 aloe
fermention products did not induce any histological lesions
in organs including liver, lung, spleen, kidneys, heart, testes,
ovaries, adrenal glands, thymus and brain (data not shown).
The intact histological findings under microscopic examination
well correlates with the normal organ weights, hematology
and blood biochemical parameters.
We obtained 3 aloe fermentation products by fermenting
aloe with 3 mushroom mycelia: aloin A and B contents in
AG from Ganoderma lucidum, AH from Hericium erinaceus
(AH) and AP from Phellinus linteus greatly increased, while
the β-glucan content significantly decreased. In the present
studies, we investigated any possible toxicities of the 3 aloe
fermentation products in rats following oral administration
once (at doses of 1, 2 and 5 g/kg) or for 28 days (at doses
of 0.5, 1 and 2 g/kg).
There was no significant difference in body weight gain
between vehicle control and AG-, AH- or AP-treated rats.
Also, significant changes in daily feed intake and water
consumption were not observed. In hematological analysis,
non of the parameters observed were affected by aloe
fermentation products with mushroom mycelia, suggestive
of no adverse effects on hematopoiesis of blood cells and
their integrity. In blood biochemistry, none of the markers
examined were affected by AG, AH or AP feeding. Similarly,
there were no significant effects on damage and functional
markers of the liver and kidneys. Supportive of the above
parameters, histopathological findings confirmed that the aloe
fermentation products did not cause any lesions in major
internal organs. In conclusion, since no adverse effects of
AG, AH or AP were observed in single- or repeated-dose
toxicity tests, even at upper-limit doses, it is suggested that
aloe fermentation products with mushroom mycelia possess
long-term safety and could be candidates for the improvement
of intestinal function and immunity.
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